Tumour necrosis factor (TNF) and interleukin-1 (IL-1) induce muscle proteolysis through different mechanisms

Oded Zamir, Per Olof Hasselgren, Takashi Higashiguchi, Janice A. Frederick, Josef E. Fischer

Research output: Contribution to journalArticlepeer-review

44 Citations (Scopus)


The purpose of this study was to test the hypothesis that muscle proteolysis induced by TNF or IL-1 is mediated by glucocorticoids. Rats were treated with 300 μg kg-1 of recombinant human preparations of IL-la (rIL-lα) or TNFα (rTNFα) divided into three equal intraperitoneal doses given over 16 h. Two hours before each cytokine injection, rats were given 5 mg kg1 of the glucocorticoid receptor blocker mifepristone RU 38486, by gavage or were gavaged with the vehicle. Eighteen hours after the first cytokine injection, total and myofibrillar protein breakdown rates were determined in incubated extensor digitorum longus muscles as release of tyrosine and 3- methylhistidine, respectively. Total and myofibrillar proteolytic rates were increased following injection of rIL-lα or rTNFα. Proteolysis induced by rIL-lα was not altered by treatment with RU 38486. In contrast, the glucocorticoid receptor blocker inhibited the proteolytic effect of rTNFα. The results suggest that the proteolytic effect of TNF is mediated by glucocorticoids and that IL-1 induces muscle proteolysis through a glucocorticoid independent pathway.

Original languageEnglish
Pages (from-to)247-250
Number of pages4
JournalMediators of Inflammation
Issue number4
Publication statusPublished - 1992

All Science Journal Classification (ASJC) codes

  • Immunology
  • Cell Biology


Dive into the research topics of 'Tumour necrosis factor (TNF) and interleukin-1 (IL-1) induce muscle proteolysis through different mechanisms'. Together they form a unique fingerprint.

Cite this